![](/img/cover-not-exists.png)
Immunogenicity and safety results from a randomized multicenter trial comparing a Tdap-IPV vaccine (REPEVAX ® ) and a tetanus monovalent vaccine in healthy adults
Laurichesse, Henri, Zimmermann, Ulrich, Galtier, Florence, Launay, Odile, Duval, Xavier, Richard, Patrick, Sadorge, Christine, Soubeyrand, BenoitVolume:
8
Language:
english
Journal:
Human Vaccines & Immunotherapeutics
DOI:
10.4161/hv.22083
Date:
December, 2012
File:
PDF, 1.01 MB
english, 2012